- Diagnosis and Clinical Features in Autoimmune-Mediated Movement Disorders
-
Hsieh PC, Wu YR
- KMID: 2530214
- J Mov Disord.
- 2022 May;15(2):95-105.
- doi: 10.14802/jmd.21077
Movement disorders are common manifestations in autoimmune-mediated encephalitis. This group of diseases is suspected to be triggered by infection or neoplasm. Certain phenotypes correlate with specific autoantibody-related neurological disorders, such... -
- CITED
-
- Close
- SHARE
-
- Close
- Re: Comment on “Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis”
-
Yoo D, Ahn TB
- KMID: 2530231
- J Mov Disord.
- 2022 May;15(2):189-189.
- doi: 10.14802/jmd.22049
-
- CITED
-
- Close
- SHARE
-
- Close
- Syringomyelia Manifesting With Pseudodystonia: A Case Report
-
Hwang YS, Lee SH, Jo S, Chung SJ
- KMID: 2530226
- J Mov Disord.
- 2022 May;15(2):175-177.
- doi: 10.14802/jmd.21121
-
- CITED
-
- Close
- SHARE
-
- Close
- Pseudodystonia and Neuropathic Tremor in a Patient With Monomelic Amyotrophy
-
Lee SH, Hwang YS, Jo S, Chung SJ
- KMID: 2530228
- J Mov Disord.
- 2022 May;15(2):181-183.
- doi: 10.14802/jmd.21138
-
- CITED
-
- Close
- SHARE
-
- Close
- Hand Movement-Induced Eyeblink Bursts in a Patient With Parkinson’s Disease
-
Yamada G, Horiba M, Toyoda T, Katada E, Matsukawa N
- KMID: 2530232
- J Mov Disord.
- 2022 May;15(2):190-192.
- doi: 10.14802/jmd.21161
-
- CITED
-
- Close
- SHARE
-
- Close
- Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale
-
- KMID: 2530221
- J Mov Disord.
- 2022 May;15(2):151-155.
- doi: 10.14802/jmd.21104
Objective This study aims to validate the Thai translation of the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Methods The English version was translated into Thai... -
- CITED
-
- Close
- SHARE
-
- Close
- Comment on “Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis”
-
Ahn BJ, Kwon KY
- KMID: 2530230
- J Mov Disord.
- 2022 May;15(2):187-188.
- doi: 10.14802/jmd.21184
-
- CITED
-
- Close
- SHARE
-
- Close
- Acute Extrapyramidal Side Effects Following Domperidone Intake in a 48-Year-Old Female Patient: The First Genetic Alteration and Drug Interaction Characterized
-
Thuan ND, Nhung VP, Dung HT, Son ND, Hai Ha N, Ton ND
- KMID: 2530233
- J Mov Disord.
- 2022 May;15(2):193-195.
- doi: 10.14802/jmd.21151
-
- CITED
-
- Close
- SHARE
-
- Close
- Asymmetric Parkinsonism With Progressive Nigrosomal Change Secondary to Kernohan’s Notch Phenomenon
-
Kim HK, Baek MS, Ahn SJ, Lyoo CH
- KMID: 2530229
- J Mov Disord.
- 2022 May;15(2):184-186.
- doi: 10.14802/jmd.21162
-
- CITED
-
- Close
- SHARE
-
- Close
- A Case of AOA2 With Compound Heterozygous SETX Mutations
-
Chang HJ, Kim R, Kim M, Moon J, Kim MJ, Kim HJ
- KMID: 2530227
- J Mov Disord.
- 2022 May;15(2):178-180.
- doi: 10.14802/jmd.21139
-
- CITED
-
- Close
- SHARE
-
- Close
- Expanding the Clinical Spectrum of RFC1 Gene Mutations
-
Kulshreshtha D, Ganguly J, Jog M
- KMID: 2530224
- J Mov Disord.
- 2022 May;15(2):167-170.
- doi: 10.14802/jmd.21117
Biallelic intronic repeat expansion in the replication factor complex unit 1 (RFC1) gene has recently been described as a cause of late onset ataxia with degeneration of the cerebellum, sensory... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Chelation Therapy on a Korean Patient With Brain Manganese Deposition Resulting From a Compound Heterozygous Mutation in the SLC39A14 Gene
-
Lee JH, Shin JH
- KMID: 2530225
- J Mov Disord.
- 2022 May;15(2):171-174.
- doi: 10.14802/jmd.21143
Mutations in the manganese transporter gene SLC39A14 lead to inherited disorders of manganese metabolism. Chelation therapy with edetate calcium disodium (CaNa2EDTA) is known to effectively reduce manganese deposition. We describe... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Outcome of Hemimasticatory Spasm
-
Ray S, Kamble N, Yadav R, Pal PK
- KMID: 2530220
- J Mov Disord.
- 2022 May;15(2):146-150.
- doi: 10.14802/jmd.21067
Objective This study aims to identify the demographic, clinical, and therapeutic characteristics of four patients with hemimasticatory spasm (HMS) seen in our outpatient department over a period of 20 years. Methods... -
- CITED
-
- Close
- SHARE
-
- Close
- Automatic Measurement of Postural Abnormalities With a Pose Estimation Algorithm in Parkinson’s Disease
-
Shin JH, Woo KA, Lee CY, Jeon SH, Kim HJ, Jeon B
- KMID: 2530219
- J Mov Disord.
- 2022 May;15(2):140-145.
- doi: 10.14802/jmd.21129
Objective This study aims to develop an automated and objective tool to evaluate postural abnormalities in Parkinson’s disease (PD) patients. Methods We applied a deep learning-based pose-estimation algorithm to lateral photos... -
- CITED
-
- Close
- SHARE
-
- Close
- Utility of Clinical Exome Sequencing in Dystonia: A Single-Center Study From India
-
Holla VV, Neeraja K, Stezin A, Prasad S, Surisetti BK, Netravathi M, Kamble N, Yadav R, Pal PK
- KMID: 2530222
- J Mov Disord.
- 2022 May;15(2):156-161.
- doi: 10.14802/jmd.21146
Objective With the use of next-generation sequencing in clinical practice, several genetic etiologies of dystonia have been identified. This study aimed to ascertain the utility of clinical exome sequencing (CES)... -
- CITED
-
- Close
- SHARE
-
- Close
- Labrune’s Syndrome Presenting With Stereotypy-Like Movements and Psychosis: A Case Report and Review
-
Sim CY, Mukari SAM, Ngu LH, Loh CY, Remli R, Ibrahim NM
- KMID: 2530223
- J Mov Disord.
- 2022 May;15(2):162-166.
- doi: 10.14802/jmd.21120
Labrune’s syndrome, or leukoencephalopathy with brain calcifications and cysts (LCC), is a rare genetic syndrome with variable neurological presentations. Psychiatric manifestations and involuntary movements are uncommonly reported. We report the... -
- CITED
-
- Close
- SHARE
-
- Close
- Umami and Other Taste Perceptions in Patients With Parkinson’s Disease
-
Jagota P, Chotechuang N, Anan C, Kitjawijit T, Boonla C, Bhidayasiri R
- KMID: 2530216
- J Mov Disord.
- 2022 May;15(2):115-123.
- doi: 10.14802/jmd.21058
Objective Studies of taste perceptions in Parkinson’s disease (PD) patients have been controversial, and none of these studies have assessed umami taste. This study aimed to assess umami, along with... -
- CITED
-
- Close
- SHARE
-
- Close
- Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy
-
Hor JW, Lim SY, Khor ES, Chong KK, Song SL, Ibrahim NM, Teh CSJ, Chong CW, Hilmi IN, Tan AH
- KMID: 2530215
- J Mov Disord.
- 2022 May;15(2):106-114.
- doi: 10.14802/jmd.21085
Objective Converging evidence suggests that intestinal inflammation is involved in the pathogenesis of neurodegenerative diseases. Previous studies on fecal calprotectin in Parkinson’s disease (PD) were limited by small sample sizes,... -
- CITED
-
- Close
- SHARE
-
- Close
- Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease
-
Jeon J, Kim K, Baek K, Chung SJ, Yoon J, Kim YJ
- KMID: 2530218
- J Mov Disord.
- 2022 May;15(2):132-139.
- doi: 10.14802/jmd.22012
Objective The Montreal Cognitive Assessment (MoCA) is recommended for assessing general cognition in Parkinson’s disease (PD). Several cutoffs of MoCA scores for diagnosing PD with cognitive impairment (PD-CI) have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Clinical Milestones in Parkinson’s Disease After Bilateral Subthalamic Deep Brain Stimulation
-
Ong JNA, Shin JH, Jeon S, Lee CY, Kim HJ, Paek SH, Jeon B
- KMID: 2530217
- J Mov Disord.
- 2022 May;15(2):124-131.
- doi: 10.14802/jmd.21106
Objective Deep brain stimulation of the subthalamic nucleus (STN-DBS) in Parkinson’s disease (PD) patients does not halt disease progression, as these patients will progress and develop disabling non-levodopa responsive symptoms.... -
- CITED
-
- Close
- SHARE
-
- Close
